Zurcher Kantonalbank (Zurich Cantonalbank) - QIAGEN NV ownership

QIAGEN NV's ticker is QGENXXXX and the CUSIP is N72482107. A total of 8 filers reported holding QIAGEN NV in Q4 2012. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Zurcher Kantonalbank (Zurich Cantonalbank) ownership history of QIAGEN NV
ValueSharesWeighting
Q4 2016$2,162,000
+0.4%
76,814
-1.8%
0.02%0.0%
Q3 2016$2,153,000
+56.9%
78,185
+23.4%
0.02%
+22.2%
Q2 2016$1,372,000
-35.3%
63,347
-33.3%
0.02%
-33.3%
Q1 2016$2,119,000
-17.3%
94,982
+1.1%
0.03%
-15.6%
Q4 2015$2,563,000
-3.3%
93,956
-8.9%
0.03%
-13.5%
Q3 2015$2,651,000
+32.8%
103,087
+26.8%
0.04%
+32.1%
Q2 2015$1,996,000
-5.7%
81,277
-3.2%
0.03%
-3.4%
Q1 2015$2,117,000
+28.8%
83,954
+17.7%
0.03%
-42.0%
Q4 2014$1,643,000
-2.2%
71,344
-12.1%
0.05%
-9.1%
Q3 2014$1,680,000
-76.1%
81,152
-77.9%
0.06%
-73.4%
Q2 2014$7,026,000
+10.2%
366,712
-5.5%
0.21%
+5.1%
Q1 2014$6,374,000
+14.8%
387,978
+29.1%
0.20%
+8.2%
Q4 2013$5,552,000
-12.6%
300,437
-16.4%
0.18%
-17.3%
Q3 2013$6,355,000
-23.0%
359,440
-23.5%
0.22%
-23.6%
Q2 2013$8,252,000
+1874.2%
470,100
+2246.7%
0.29%
+1820.0%
Q1 2013$418,000
+34.0%
20,032
+16.6%
0.02%
+25.0%
Q4 2012$312,000
-1.6%
17,1840.0%0.01%
-7.7%
Q3 2012$317,000
+36.1%
17,184
+23.7%
0.01%
+30.0%
Q2 2012$233,000
-67.7%
13,896
-70.0%
0.01%
-68.8%
Q1 2012$721,000
+43.6%
46,353
+27.7%
0.03%
+39.1%
Q4 2011$502,00036,2880.02%
Other shareholders
QIAGEN NV shareholders Q4 2012
NameSharesValueWeighting ↓
Exane Asset Management 642,752$14,260,214,0005.53%
Tikvah Management LLC 369,425$8,057,0004.72%
Hardman Johnston Global Advisors LLC 3,797,024$82,813,0004.22%
HealthCor Management, L.P. 2,500,000$54,525,0002.97%
Opus Point Partners Management, LLC 105,751$2,306,0002.23%
CRAMER ROSENTHAL MCGLYNN LLC 4,018,074$87,634,0001.41%
Douglas Lane & Associates, LLC 1,942,678$42,370,0001.22%
PLATINUM INVESTMENT MANAGEMENT LTD 2,167,768$47,279,0001.17%
MANNING & NAPIER ADVISORS LLC 6,111,364$133,287,0000.81%
PRIMECAP MANAGEMENT CO/CA/ 20,128,325$438,999,0000.47%
View complete list of QIAGEN NV shareholders